share_log

Athira Pharma FY 2024 GAAP EPS $(2.52) Beats $(2.54) Estimate

Benzinga ·  Feb 27 21:43

Athira Pharma (NASDAQ:ATHA) reported quarterly losses of $(2.52) per share which beat the analyst consensus estimate of $(2.54) by 0.79 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 371

Recommended

Write a comment